<p>Kaplan–Meier estimates for survival in patients with cirrhosis and esophageal variceal bleeding (1 year follow-up).</p
<p>Subgroup analysis of one-year cumulative survival in patients pooled from the training cohort and...
<p>Kaplan–Meier survival curve in advanced-stage hepatocellular carcinoma patients receiving sorafen...
Kaplan Meier estimates of overall survival (OS) in patients with (IRSLs+) or without immune relate s...
<p>Kaplan–Meier estimates for the absence of re-bleeding in patients with cirrhosis and esophageal v...
Kaplan–Meier survival analysis of 30-day mortality of cirrhotic patients with different bacterial in...
Kaplan–Meier survival analysis of 30-day mortally of cirrhotic patients with bacterial infections us...
Kaplan-Meier survival curves comparing in-patient survival probabilities between liver cirrhosis pat...
Kaplan–Meier estimates of overall survival in patients with and without sarcopenia.</p
<p>Wilson’s disease patients (blue line) and general liver transplantation population (green line).<...
<p>Kaplan–Meier estimates of overall survival between patients with locoregional recurrence and thos...
<p>The difference in survival between patients with cirrhosis and without cirrhosis was statisticall...
<p>Kaplan-Meier estimates of overall survival of patients with alcohol drinking versus without alcoh...
Kaplan-Meier survival estimates for unfavorable outcomes among HIV positive patients.</p
Kaplan–Meier estimates of (A) primary and (B) secondary AVF patency rates, and (C) the overall patie...
<p>Kaplan Meier CV survival estimates according to GLS in patients with preserved EF.</p
<p>Subgroup analysis of one-year cumulative survival in patients pooled from the training cohort and...
<p>Kaplan–Meier survival curve in advanced-stage hepatocellular carcinoma patients receiving sorafen...
Kaplan Meier estimates of overall survival (OS) in patients with (IRSLs+) or without immune relate s...
<p>Kaplan–Meier estimates for the absence of re-bleeding in patients with cirrhosis and esophageal v...
Kaplan–Meier survival analysis of 30-day mortality of cirrhotic patients with different bacterial in...
Kaplan–Meier survival analysis of 30-day mortally of cirrhotic patients with bacterial infections us...
Kaplan-Meier survival curves comparing in-patient survival probabilities between liver cirrhosis pat...
Kaplan–Meier estimates of overall survival in patients with and without sarcopenia.</p
<p>Wilson’s disease patients (blue line) and general liver transplantation population (green line).<...
<p>Kaplan–Meier estimates of overall survival between patients with locoregional recurrence and thos...
<p>The difference in survival between patients with cirrhosis and without cirrhosis was statisticall...
<p>Kaplan-Meier estimates of overall survival of patients with alcohol drinking versus without alcoh...
Kaplan-Meier survival estimates for unfavorable outcomes among HIV positive patients.</p
Kaplan–Meier estimates of (A) primary and (B) secondary AVF patency rates, and (C) the overall patie...
<p>Kaplan Meier CV survival estimates according to GLS in patients with preserved EF.</p
<p>Subgroup analysis of one-year cumulative survival in patients pooled from the training cohort and...
<p>Kaplan–Meier survival curve in advanced-stage hepatocellular carcinoma patients receiving sorafen...
Kaplan Meier estimates of overall survival (OS) in patients with (IRSLs+) or without immune relate s...